MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Exercise of Options and Director Dealing

RNS

RNS Number : 2530D
Judges Scientific PLC
26 October 2020
 

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Exercise of Options and Director dealing

 

The Company has today issued 10,000 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options at a price of £14.38 under the Company's Unapproved Share Option Scheme. The new Ordinary Shares are being issued under the Company's current blocklisting.

The options were exercised by the Group Finance Director, Brad Ormsby. They were granted shortly after he joined the Company in March 2015.  He has today also sold 10,000 Ordinary Shares at £52.00 per Ordinary Share. Following the exercise and sale, Brad Ormsby's holding in the Company is unchanged at 3,719 Ordinary Shares representing 0.06 per cent. of the issued Ordinary share capital. 

Following the allotment of these shares, the enlarged issued Ordinary share capital will be 6,292,024 Ordinary Shares .

 

For further information please contact:

  Judges Scientific

 

 

  David Cicurel, CEO

  Brad Ormsby, Group FD

Tel: +44 (0) 203829 6970

 

 

  Shore Capital (Nominated Adviser & Broker)

 

  Stephane Auton

  Edward Mansfield

  Sarah Mather

Tel: +44 (0) 20 7408 4090

 

  Liberum (Joint Broker)

  Bidhi Bhoma

  Euan Brown

 

  Media enquiries :

  Alma PR (Financial Public Relations)

 

Tel: +44 (0) 20 3100 2222

  Rebecca Sanders-Hewett

  Sam Modlin

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Bradley Ormsby

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Finance Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Exercise of options and subsequent sale of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1437.5p

10,000

5200.0p

10,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (two separate single transactions)

e)

 

Date of the transaction

 

 

26/10/2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMFBRTMTBTBIM